Baxter International Inc. (NYSE: BAX)’s stock price has increased by 0.05 compared to its previous closing price of 36.57. However, the company has seen a -0.16% decrease in its stock price over the last five trading sessions. reuters.com reported 2024-10-21 that Baxter International on Monday said that it aims to restore the number of new patients able to begin using its peritoneal dialysis solutions to pre-Hurricane Helene levels by the end of the year.
Is It Worth Investing in Baxter International Inc. (NYSE: BAX) Right Now?
The 36-month beta value for BAX is also noteworthy at 0.60. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 2 rating it as “overweight,” 9 rating it as “hold,” and 1 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for BAX is 506.36M, and at present, short sellers hold a 2.37% of that float. The average trading volume of BAX on October 23, 2024 was 4.01M shares.
BAX’s Market Performance
BAX’s stock has seen a -0.16% decrease for the week, with a -6.18% drop in the past month and a 3.10% gain in the past quarter. The volatility ratio for the week is 1.56%, and the volatility levels for the past 30 days are at 2.45% for Baxter International Inc. The simple moving average for the last 20 days is -1.04% for BAX stock, with a simple moving average of -3.51% for the last 200 days.
Analysts’ Opinion of BAX
Many brokerage firms have already submitted their reports for BAX stocks, with Morgan Stanley repeating the rating for BAX by listing it as a “Underweight.” The predicted price for BAX in the upcoming period, according to Morgan Stanley is $30 based on the research report published on July 15, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see BAX reach a price target of $36. The rating they have provided for BAX stocks is “Neutral” according to the report published on May 30th, 2024.
TD Cowen gave a rating of “Hold” to BAX, setting the target price at $40 in the report published on May 10th of the current year.
BAX Trading at -2.62% from the 50-Day Moving Average
After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.85% of loss for the given period.
Volatility was left at 2.45%, however, over the last 30 days, the volatility rate increased by 1.56%, as shares sank -6.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.92% lower at present.
During the last 5 trading sessions, BAX fell by -0.16%, which changed the moving average for the period of 200-days by -6.56% in comparison to the 20-day moving average, which settled at $36.97. In addition, Baxter International Inc. saw -5.35% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BAX starting from Stevens Brian, who proposed sale 976 shares at the price of $40.01 back on Sep 16 ’24. After this action, Stevens Brian now owns shares of Baxter International Inc., valued at $39,046 using the latest closing price.
Stevens Brian, the Officer of Baxter International Inc., proposed sale 16,063 shares at $39.81 during a trade that took place back on Sep 13 ’24, which means that Stevens Brian is holding shares at $639,465 based on the most recent closing price.
Stock Fundamentals for BAX
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.36 for the gross margin
The net margin for Baxter International Inc. stands at 0.17. The total capital return value is set at 0.05. Equity return is now at value -2.38, with -0.58 for asset returns.
Based on Baxter International Inc. (BAX), the company’s capital structure generated 0.63 points at debt to capital in total, while cash flow to debt ratio is standing at 0.09. The debt to equity ratio resting at 1.69. The interest coverage ratio of the stock is 2.12.
Currently, EBITDA for the company is 1.75 billion with net debt to EBITDA at 5.66. When we switch over and look at the enterprise to sales, we see a ratio of 1.99. The receivables turnover for the company is 5.57for trailing twelve months and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.40.
Conclusion
In summary, Baxter International Inc. (BAX) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
